2016
DOI: 10.1038/srep27623
|View full text |Cite
|
Sign up to set email alerts
|

Multiplex giant magnetoresistive biosensor microarrays identify interferon-associated autoantibodies in systemic lupus erythematosus

Abstract: High titer, class-switched autoantibodies are a hallmark of systemic lupus erythematosus (SLE). Dysregulation of the interferon (IFN) pathway is observed in individuals with active SLE, although the association of specific autoantibodies with chemokine score, a combined measurement of three IFN-regulated chemokines, is not known. To identify autoantibodies associated with chemokine score, we developed giant magnetoresistive (GMR) biosensor microarrays, which allow the parallel measurement of multiple serum ant… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
22
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
2
1

Relationship

4
5

Authors

Journals

citations
Cited by 31 publications
(22 citation statements)
references
References 43 publications
0
22
0
Order By: Relevance
“…Sensitive and accurate biosensing systems for these biomarkers can not only significantly aid in the early diagnosis and clinical management of AIDs but also help to establish therapeutic strategies [ 4 ]. Biosensors for the detection of autoantibodies specific to AIDs, including antiphospholipid syndrome (APS) [ 91 , 92 , 93 , 94 ], rheumatoid arthritis (RA) [ 95 , 96 , 97 , 98 , 99 ], systemic lupus erythematosus (SLE) [ 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 ], multiple sclerosis (MS) [ 108 , 109 , 110 , 111 ], and celiac disease (CD) [ 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 ], are now constructed based on diverse techniques with many advantages, including high sensitivity and easy operation.…”
Section: Potential Applications Of Antibody Biosensing For Clinicamentioning
confidence: 99%
See 1 more Smart Citation
“…Sensitive and accurate biosensing systems for these biomarkers can not only significantly aid in the early diagnosis and clinical management of AIDs but also help to establish therapeutic strategies [ 4 ]. Biosensors for the detection of autoantibodies specific to AIDs, including antiphospholipid syndrome (APS) [ 91 , 92 , 93 , 94 ], rheumatoid arthritis (RA) [ 95 , 96 , 97 , 98 , 99 ], systemic lupus erythematosus (SLE) [ 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 ], multiple sclerosis (MS) [ 108 , 109 , 110 , 111 ], and celiac disease (CD) [ 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 ], are now constructed based on diverse techniques with many advantages, including high sensitivity and easy operation.…”
Section: Potential Applications Of Antibody Biosensing For Clinicamentioning
confidence: 99%
“…Other techniques such as giant magnetoresistive (GMR) biosensor microarrays have been designed to analyze serum samples from SLE patients and have also been shown to be capable of identifying autoantibodies associated with relevant clinical manifestations of SLE, with potential for use as biomarkers in clinical practice [ 101 ].…”
Section: Potential Applications Of Antibody Biosensing For Clinicamentioning
confidence: 99%
“…We have developed magneto-nanosensors capable of monitoring multiple proteins at femtomolar sensitivities with a large dynamic range 16 , 17 . The magneto-nanosensors have been demonstrated for the detection of radiation biomarkers 18 , autoantibodies 19 , 20 , and small molecules 21 as well as for monitoring protein-protein interactions 22 , 23 . Here, we present a method using magneto-nanosensors with 6-plex cytokine assays to measure longitudinal protein profiles in response to cyclophosphamide treatment in mouse lymphoma models.…”
Section: Introductionmentioning
confidence: 99%
“…Second, the GMR sensors can be arrayed for multiplexed detection in a single assay without the need for optical scanning. Third, magnetic sensors are insensitive to the sample matrix, allowing them to be used with a wide variety of samples with minimal sample preparation 39 , making then convenient for use in point-of-care (POC) or point-of-use (POU) settings 40 . Lastly, the sensors continuously quantify the local magnetic field changes enabling real-time monitoring of the assay.…”
mentioning
confidence: 99%